{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:45:35Z","timestamp":1777675535105,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019K2A9A1A06091603"],"award-info":[{"award-number":["NRF-2019K2A9A1A06091603"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["GrantNRF-2019K2A9A1A06091603"],"award-info":[{"award-number":["GrantNRF-2019K2A9A1A06091603"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["119N234"],"award-info":[{"award-number":["119N234"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jpet.2026.103811","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:39:34Z","timestamp":1771400374000},"page":"103811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-driven discovery of potent isocitrate dehydrogenase 1 mutant inhibitors from ultralarge ligand libraries for targeting malignant glioma"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-5260","authenticated-orcid":false,"given":"Mehreen","family":"Zaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0737-1644","authenticated-orcid":false,"given":"Fareed","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeyma","family":"\u00d6zkanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuman","family":"\u00c7elebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5889-8907","authenticated-orcid":false,"given":"Hangun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fcrker","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timu\u00e7in","family":"Av\u015far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0426-0905","authenticated-orcid":false,"given":"Serdar","family":"Durda\u011f\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jpet.2026.103811_bib1","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: current state, challenges, and future perspectives","volume":"21","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"10.1016\/j.jpet.2026.103811_bib2","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3390\/cancers15112883","article-title":"Mutant IDH in gliomas: role in cancer and treatment options","volume":"15","author":"Solomou","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.jpet.2026.103811_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/15384047.2019.1599662","article-title":"Glioblastoma vs temozolomide: can the red queen race be won?","volume":"20","author":"Arora","year":"2019","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"10.1016\/j.jpet.2026.103811_bib4","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.ajpath.2015.02.023","article-title":"Molecular and genomic alterations in glioblastoma multiforme","volume":"185","author":"Crespo","year":"2015","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.jpet.2026.103811_bib5","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Sottoriva","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7319","key":"10.1016\/j.jpet.2026.103811_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jpet.2026.103811_bib7","first-page":"894","article-title":"Differences in protein expression between the U251 and U87 cell lines","volume":"27","author":"Li","year":"2017","journal-title":"Turk Neurosurg"},{"issue":"11","key":"10.1016\/j.jpet.2026.103811_bib8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2026.103811_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/cancers10020049","article-title":"Beyond brooding on oncometabolic havoc in IDH-mutant gliomas and AML: current and future therapeutic strategies","volume":"10","author":"Madala","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"7274","key":"10.1016\/j.jpet.2026.103811_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"6132","key":"10.1016\/j.jpet.2026.103811_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1234769","article-title":"Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jpet.2026.103811_bib12","first-page":"59","article-title":"Complex role of HIF in cancer: the known, the unknown, and the unexpected","volume":"2","author":"Tiburcio","year":"2014","journal-title":"Hypoxia (Auckl)"},{"issue":"13","key":"10.1016\/j.jpet.2026.103811_bib13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/ars.2019.7902","article-title":"2-Hydroxyglutarate in cancer cells","volume":"33","author":"Je\u017eek","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"6132","key":"10.1016\/j.jpet.2026.103811_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells","volume":"340","author":"Rohle","year":"2013","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.jpet.2026.103811_bib15","doi-asserted-by":"crossref","first-page":"13717","DOI":"10.1074\/jbc.M113.511030","article-title":"Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1","volume":"289","author":"Davis","year":"2014","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.103811_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.M114.608497","article-title":"Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule","volume":"290","author":"Deng","year":"2015","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.jpet.2026.103811_bib17","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/j.bmcl.2015.10.034","article-title":"Discovery of \u03b1-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1","volume":"25","author":"Kim","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/j.jpet.2026.103811_bib18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nchembio.1930","article-title":"New IDH1 mutant inhibitors for treatment of acute myeloid leukemia","volume":"11","author":"Okoye-Okafor","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"10","key":"10.1016\/j.jpet.2026.103811_bib19","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acsmedchemlett.6b00264","article-title":"Discovery of 8-membered ring sulfonamides as inhibitors of oncogenic mutant isocitrate dehydrogenase 1","volume":"7","author":"Law","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"10","key":"10.1016\/j.jpet.2026.103811_bib20","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/leu.2017.46","article-title":"Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.jpet.2026.103811_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.str.2016.12.017","article-title":"Allosteric mutant IDH1 inhibitors reveal mechanisms for IDH1 mutant and isoform selectivity","volume":"25","author":"Xie","year":"2017","journal-title":"Structure"},{"issue":"42","key":"10.1016\/j.jpet.2026.103811_bib22","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1038\/s41388-019-0929-9","article-title":"Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma","volume":"38","author":"Nakagawa","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jpet.2026.103811_bib23","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/acs.jmedchem.9b01423","article-title":"Structure-based design and identification of FT-2102 (olutasidenib), a potent mutant-selective IDH1 inhibitor","volume":"63","author":"Caravella","year":"2020","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.103811_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acsmedchemlett.9b00509","article-title":"Vorasidenib (AG-881): a first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma","volume":"11","author":"Konteatis","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jpet.2026.103811_bib25","article-title":"Discovery of novel IDH1 inhibitor through comparative structure-based virtual screening","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.103811_bib26","series-title":"Probe Reports from the NIH Molecular Libraries Program","article-title":"ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells","author":"Davis","year":"2010"},{"key":"10.1016\/j.jpet.2026.103811_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40364-019-0173-z","article-title":"Isocitrate dehydrogenase inhibitors in acute myeloid leukemia","volume":"7","author":"Liu","year":"2019","journal-title":"Biomark Res"},{"key":"10.1016\/j.jpet.2026.103811_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-bioeng-071910-124729","article-title":"Multiscale cancer modeling","volume":"13","author":"Deisboeck","year":"2011","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"10.1016\/j.jpet.2026.103811_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/nen.0b013e31802d9000","article-title":"The evolution of mathematical modeling of glioma proliferation and invasion","volume":"66","author":"Harpold","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jpet.2026.103811_bib30","series-title":"Selected Topics in Cancer Modeling: Genesis, Evolution, Immune Competition, and Therapy","first-page":"1","article-title":"Modeling diffusely invading brain tumors: an individualized approach to quantifying glioma evolution and response to therapy","author":"Rockne","year":"2008"},{"issue":"2","key":"10.1016\/j.jpet.2026.103811_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acsmedchemlett.6b00334","article-title":"Optimization of 3-pyrimidin-4-yl-oxazolidin-2-ones as allosteric and mutant specific inhibitors of IDH1","volume":"8","author":"Levell","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jpet.2026.103811_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejmech.2018.12.033","article-title":"Recent advances in the discovery of small molecules targeting glioblastoma","volume":"164","author":"Fernandes","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.jpet.2026.103811_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1359-6446(05)03376-3","article-title":"Text-mining approaches in molecular biology and biomedicine","volume":"10","author":"Krallinger","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpet.2026.103811_bib34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ejmech.2014.12.011","article-title":"Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents","volume":"90","author":"Mondal","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"23","key":"10.1016\/j.jpet.2026.103811_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40404","article-title":"Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies","volume":"10","author":"Banerjee","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.jpet.2026.103811_bib36","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1080\/07391102.2018.1491423","article-title":"Novel tumor necrosis factor-\u03b1 (TNF-\u03b1) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models","volume":"37","author":"Zaka","year":"2019","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jpet.2026.103811_bib37","series-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"issue":"24","key":"10.1016\/j.jpet.2026.103811_bib38","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1021\/j100308a038","article-title":"The missing term in effective pair potentials","volume":"91","author":"Berendsen","year":"1987","journal-title":"J Phys Chem"},{"issue":"1","key":"10.1016\/j.jpet.2026.103811_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00268977200100031","article-title":"NpT-ensemble Monte Carlo calculations for binary liquid mixtures","volume":"23","author":"McDonald","year":"1972","journal-title":"Mol Phys"},{"issue":"1","key":"10.1016\/j.jpet.2026.103811_bib40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1063\/1.447334","article-title":"A unified formulation of the constant temperature molecular dynamics methods","volume":"81","author":"Nos\u00e9","year":"1984","journal-title":"J Chem Phys"},{"issue":"5","key":"10.1016\/j.jpet.2026.103811_bib41","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J Chem Phys"},{"issue":"19","key":"10.1016\/j.jpet.2026.103811_bib42","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"key":"10.1016\/j.jpet.2026.103811_bib43","article-title":"Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: an in silico perspective for the identification of new potential HDAC3 inhibitors","volume":"166","author":"Lanka","year":"2006","journal-title":"Comput Biol Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.103811_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11030-024-10837-5","article-title":"Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches","volume":"29","author":"Lanka","year":"2025","journal-title":"Mol Divers"},{"issue":"11","key":"10.1016\/j.jpet.2026.103811_bib45","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1021\/ct200462q","article-title":"IDSite: an accurate approach to predict P450-mediated drug metabolism","volume":"7","author":"Li","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.jpet.2026.103811_bib46","series-title":"Schr\u00f6dinger Release 2018-4: Prime","year":"2018"},{"key":"10.1016\/j.jpet.2026.103811_bib47","series-title":"Schr\u00f6dinger Release 2018-4: Core Hopping","year":"2018"},{"key":"10.1016\/j.jpet.2026.103811_bib48","series-title":"Schr\u00f6dinger Release 2018-4: CombiGlide","year":"2018"},{"key":"10.1016\/j.jpet.2026.103811_bib49","series-title":"Schr\u00f6dinger Release 2022-1: Ligand Designer","year":"2022"},{"issue":"8","key":"10.1016\/j.jpet.2026.103811_bib50","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acs.jcim.2c00072","article-title":"AutoDesigner, a de novo design algorithm for rapidly exploring large chemical space for lead optimization: application to the design and synthesis of D-amino acid oxidase inhibitors","volume":"62","author":"Bos","year":"2022","journal-title":"J Chem Inf Model"},{"issue":"12","key":"10.1016\/j.jpet.2026.103811_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10822-013-9689-8","article-title":"Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics","volume":"27","author":"Wang","year":"2013","journal-title":"J Comput Aided Mol Des"},{"issue":"7","key":"10.1016\/j.jpet.2026.103811_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005659","article-title":"OpenMM 7: rapid development of high performance algorithms for molecular dynamics","volume":"13","author":"Eastman","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"20","key":"10.1016\/j.jpet.2026.103811_bib53","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1063\/1.1472510","article-title":"On the Hamiltonian replica exchange method for efficient sampling of biomolecular systems: application to protein structure prediction","volume":"116","author":"Fukunishi","year":"2002","journal-title":"J Chem Phys"},{"key":"10.1016\/j.jpet.2026.103811_bib54","unstructured":"PyMOL: The PyMOL Molecular Graphics System, Version 2. Schr\u00f6dinger, LLC."},{"issue":"11","key":"10.1016\/j.jpet.2026.103811_bib55","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J Comput Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.103811_bib56","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"issue":"45","key":"10.1016\/j.jpet.2026.103811_bib57","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1021\/jp048385l","article-title":"Early unfolding response of a stable protein domain to environmental changes","volume":"108","author":"Perera","year":"2004","journal-title":"J Phys Chem A"},{"issue":"8","key":"10.1016\/j.jpet.2026.103811_bib58","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jcc.540130812","article-title":"The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method","volume":"13","author":"Kumar","year":"1992","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jpet.2026.103811_bib59","article-title":"Development of machine learning-based QSAR models for the designing of novel anti-cancer therapeutics against malignant glioma","author":"Asaad","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jpet.2026.103811_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.927570","article-title":"Sequence-structure functional implications and molecular simulation of high deleterious nonsynonymous substitutions in IDH1 revealed the mechanism of drug resistance in glioma","volume":"13","author":"Suleman","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103811_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.slasd.2022.09.002","article-title":"Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis","volume":"28","author":"Culley","year":"2023","journal-title":"SLAS Discov"},{"key":"10.1016\/j.jpet.2026.103811_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.848353","article-title":"Application of per-residue energy decomposition to design peptide inhibitors of PSD95 GK domain","volume":"9","author":"Tian","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.103811_bib63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol Cancer"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:15:46Z","timestamp":1777450546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0022356526000091"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103811","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning-driven discovery of potent isocitrate dehydrogenase 1 mutant inhibitors from ultralarge ligand libraries for targeting malignant glioma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103811"}}